Ordan
Principal executive officer pay for Ordan, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Pediatrix Medical Group, Inc. (MD) FY2020–FY2025
Beat peersTSR -1% vs peer group -41% over FY2020–FY2025
Turnaround$100 invested moved from behind the peer group ($88.31 vs $131.41) to ahead ($87.16 vs $77.88) over FY2020–FY2025
Paid for declineCAP $6,438,682→$24,892,348 while $100 invested went $88.31→$87.16 (FY2020–FY2025)
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2020 | $6.4M | $6.4M |
| FY2021 | $6.8M | $9.0M |
| FY2022 | $4.7M | $540,703 |
| FY2023 | $4.7M | — |
| FY2025 | $14.1M | $24.9M |
The company's "$100 invested" index ran $88.31 at FY2020 → $87.16 by FY2025 — an annualized return of -0.3%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: -0.3%/yr at MD ( FY2020–FY2025). See the CEO track-record ranking for context.